• arclein
In its first preliminary human tests, the medicine in the new shot lowered low density lipoprotein, or “bad” cholesterol, in healthy volunteers who received the highest dose an average 64 percent more than those who received an inactive placebo injection.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: